Fernando Dela Cruz

Title: Innovations of Fernando Dela Cruz

Introduction

Fernando Dela Cruz is an accomplished inventor based in Fairless Hills, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying compounds that interact with the Drosophila ultraspiracle protein.

Latest Patents

Dela Cruz holds a patent for a "Screen for ultraspiracle inhibitors." This invention discloses methods for identifying compounds, variant nuclear proteins, and other auxiliary proteins that interfere with the Drosophila ultraspiracle protein ('Usp') and its homologs. The methods involve transformed yeast cells containing a Usp binding partner, which can bind with the Usp binding partner, and a reporter gene that requires a functional Usp-Usp binder partner complex for expression. The transformed yeast cells are incubated in the presence of a test compound to form a test culture and in the absence of a test compound to form a control culture. The expression of the reporter gene is monitored by exposing the test and control cultures to canavanine under conditions where control cultures exhibit reduced growth, allowing for the detection of test cultures in which growth is increased relative to control cultures.

Career Highlights

Dela Cruz is associated with the American Cyanamid Company, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in the understanding of protein interactions and their implications in various biological processes.

Collaborations

Some of his notable coworkers include Julia N Heinrich and Donald R Kirsch, who have collaborated with him on various projects, enhancing the research output and innovation at their workplace.

Conclusion

Fernando Dela Cruz's contributions to biotechnology through his patent on ultraspiracle inhibitors exemplify the impact of innovative thinking in scientific research. His work continues to influence the field and inspire future advancements.